Rowan Digital Works - Rowan-Virtua Research Day: Polypharmacy as a Treatment Barrier in Autism Spectrum Disorder
 

Author(s)

Ahmed AlyFollow

College

Rowan-Virtua School of Osteopathic Medicine

Keywords

Polypharmacy, Autism Spectrum Disorder, Neurotypical, depression, antipsychotics

Date of Presentation

5-1-2025 12:00 AM

Poster Abstract

The purpose of the study is to assess the prevalence of polypharmacy in current literature in the Autism Spectrum Disorder (ASD) population. It is hypothesized to find patients with ASD over prescribed compared to the neurotypical counterparts.

Disciplines

Medicine and Health Sciences | Pharmaceutical Preparations | Psychiatric and Mental Health | Psychiatry

Share

COinS
 
May 1st, 12:00 AM

Polypharmacy as a Treatment Barrier in Autism Spectrum Disorder

The purpose of the study is to assess the prevalence of polypharmacy in current literature in the Autism Spectrum Disorder (ASD) population. It is hypothesized to find patients with ASD over prescribed compared to the neurotypical counterparts.

 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.